CN1037322C - Dispensation of Chinese herbs oral liquid adjuvant - Google Patents

Dispensation of Chinese herbs oral liquid adjuvant Download PDF

Info

Publication number
CN1037322C
CN1037322C CN 92114412 CN92114412A CN1037322C CN 1037322 C CN1037322 C CN 1037322C CN 92114412 CN92114412 CN 92114412 CN 92114412 A CN92114412 A CN 92114412A CN 1037322 C CN1037322 C CN 1037322C
Authority
CN
China
Prior art keywords
oral liquid
liquid adjuvant
beta
schardinger dextrin
dispensation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CN 92114412
Other languages
Chinese (zh)
Other versions
CN1088113A (en
Inventor
吴泰华
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guangzhou Baiyun Shan Ming Xing Pharmaceutical Co., Ltd.
Original Assignee
Guangzhou mingxing pharmaceutical factory
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guangzhou mingxing pharmaceutical factory filed Critical Guangzhou mingxing pharmaceutical factory
Priority to CN 92114412 priority Critical patent/CN1037322C/en
Publication of CN1088113A publication Critical patent/CN1088113A/en
Application granted granted Critical
Publication of CN1037322C publication Critical patent/CN1037322C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention relates to oral liquid adjuvant of Chinese herbal medicines, which has the functions of antipyresis, detoxication and sedation. The oral liquid adjuvant comprises belta-cyclodextrin, cane sugar, menthol and water as the rest. The present invention has the advantages of good taste and no effect on the stability of main medicines.

Description

Beta-schardinger dextrin-is used to prepare QINGKAILING KOUFUYE
The present invention relates to beta-schardinger dextrin-and be used to prepare a kind of Chinese herbal medicine oral liquid QINGKAILING KOUFUYE with heat-clearing and toxic substances removing, calm sedative action.
QINGKAILING, " new medicine and pharmacology magazine " 1975 the 8th, 9 phases have been reported its injection and preparation method thereof, on the basis of injection, stevioside, Mentholum have been added, change oral liquid into, and obtained new drug and produced certification, produce according to ministry standard WS2-23 (X-14)-88.The adjuvant of the QINGKAILING KOUFUYE of applicant's Mingxing Pharmaceutical Factory, Guangzhou employing at present is stevioside 0.36%, Mentholum 0.0132% (weight/volume percent), and surplus is moisture.This oral liquid mouthfeel that this adjuvant prescription is made is poor, and patient is difficult to accept, and bitter, fishy smell weighs, and influential to the quality stability of principal agent.
Purpose of the present invention is exactly poor in order to overcome the made oral liquid mouthfeel of this adjuvant prescription, to the influential shortcoming of the quality stability of principal agent, adopts beta-schardinger dextrin-in QINGKAILING KOUFUYE, makes mouthfeel good, especially increases principal agent quality stability.
The present invention is achieved in that and gets beta-schardinger dextrin-, and sucrose is in the molten water, promptly.
The content of beta-schardinger dextrin-of the present invention can be 0.2~1.0%, sucrose 5~38% (weight/volume percent), and all the other are water.
The present invention can also add 0.005%~0.05% Mentholum.
Embodiment 1, gets 0.5 gram beta-schardinger dextrin-, and 30 gram sucrose add in 100 ml waters.
Embodiment 2, get 0.5 gram beta-schardinger dextrin-, 30 gram sucrose, and 0.01 gram Mentholum adds in 100 ml waters.
Get the oral liquid that oral liquid that embodiment 1, embodiment 2 adjuvants make and supplementary material are made, randomly draw 142 people, carry out the mouthfeel investigation, its statistical result is as follows:
Sample is imitated the product fruit Supplementary material lot number 900313-15 Embodiment 1 lot number 900329-1 Embodiment 2 lot number 900412-1
Think that mouthfeel is good, better Number 25 127 128
Percentage ratio (%) 17.6 90.1 90.1
Think that mouthfeel is poor Number 117 14 14
Percentage ratio (%) 82.4 9.9 9.9
Each is a collection of to get oral liquid that oral liquid that supplementary material makes and embodiment 1 make, with its main constituent baicalin is testing index, adopt acute destructive testing, according to the Arrhenius formula, measure it and drop to for 90% time, the result shows that the factory of oral liquid above 2 years that embodiment 1 makes is responsible for the phase, and the factory that adopts supplementary material not reach 2 years is responsible for the phase.
Supplementary material (lot number 880504) Embodiment 1 (lot number 900404-1)
12 months 28 months
Consider that Mentholum is to the quality stability did not influence of principal agent, so do not investigate the stability experiment of embodiment 2 among the embodiment 2.
Beta-schardinger dextrin-of the present invention adds in the QINGKAILING KOUFUYE, makes mouthfeel good, especially increases principal agent quality stability.

Claims (3)

1. beta-schardinger dextrin-is used to prepare QINGKAILING KOUFUYE.
2. beta-schardinger dextrin-according to claim 1 is used to prepare QINGKAILING KOUFUYE, it is characterized in that beta-schardinger dextrin-content in drug solution is 0.2~1.0% weight/volume percent.
3. beta-schardinger dextrin-according to claim 1 is used to prepare QINGKAILING KOUFUYE, it is characterized in that beta-schardinger dextrin-content in drug solution is 0.5% weight/volume percent.
CN 92114412 1992-12-08 1992-12-08 Dispensation of Chinese herbs oral liquid adjuvant Expired - Lifetime CN1037322C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 92114412 CN1037322C (en) 1992-12-08 1992-12-08 Dispensation of Chinese herbs oral liquid adjuvant

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 92114412 CN1037322C (en) 1992-12-08 1992-12-08 Dispensation of Chinese herbs oral liquid adjuvant

Publications (2)

Publication Number Publication Date
CN1088113A CN1088113A (en) 1994-06-22
CN1037322C true CN1037322C (en) 1998-02-11

Family

ID=4946916

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 92114412 Expired - Lifetime CN1037322C (en) 1992-12-08 1992-12-08 Dispensation of Chinese herbs oral liquid adjuvant

Country Status (1)

Country Link
CN (1) CN1037322C (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1101184C (en) * 1999-04-12 2003-02-12 远达药业集团哈尔滨一洲制药有限公司 Process for preparing medical particles Qingkailing by wrapping chololic acid and animal extract with cyclodextrin
CN1939424B (en) * 2006-09-26 2012-05-23 河南福森药业有限公司 Preparation process of Rhizoma corydalis analgetic oral liquid

Also Published As

Publication number Publication date
CN1088113A (en) 1994-06-22

Similar Documents

Publication Publication Date Title
Lindenmuth et al. The efficacy of echinacea compound herbal tea preparation on the severity and duration of upper respiratory and flu symptoms: a randomized, double-blind placebo-controlled study
US20060275520A1 (en) White peony extract for improving the duration and quality of sleep
CN102836340A (en) Pharmaceutical composition for benefiting vital energy, enriching blood and nourishing liver and kidney as well as preparation method and application thereof
CN105764519B (en) For treating the composition based on plant of cough
CN1037322C (en) Dispensation of Chinese herbs oral liquid adjuvant
Jenkins et al. Effect of desmopressin on normal and impaired memory
CN107158118A (en) Solid beverage with anti-alcoholic function and sobering-up function and preparation method thereof
CN113710262B (en) Scutellaria baicalensis composition and method for taste modulation
CN109464540B (en) Spray for relieving discomfort of oral cavity and throat and preparation method thereof
CN107456491A (en) A kind of Chinese medicine for treating rhinitis preparation and preparation method thereof
CN104666832B (en) Chinese herbal granules for the treatment of flu and repeated cold and preparation method thereof
CN107802678A (en) A kind of scattered preparation method of larynx health
JPS6437272A (en) Carbonated beverage raw liquid preparation
CN1284301A (en) Public beverage of Chinese herbal medicines
CN104706918B (en) Treat Chinese materia medica syrup of cold in children and repeated cold and preparation method thereof
CN112386661A (en) Composition for treating cough, preparation method and preparation
CN103656137A (en) Traditional Chinese medicine composition for dispelling wind, relieving heat, stopping cough and resolving phlegm and preparation method thereof
CN109200183A (en) A kind of herbal composite and preparation method thereof and product
CN104585469A (en) Chewing gum having protective effect on alcoholic liver injury and preparation method of chewing gum
Ouédraogo et al. p> Quality control and standardization of FACA® syrup</p>
KR101720681B1 (en) Composition for promoting sleep including hop extract
CN103610052A (en) Food, health-care product or medicament composition for prompting digestive function of stomach and intestine as well as preparation method and application thereof
DE102004033785A1 (en) Soothing herbal supplement combination with aromatherapy components, their preparation and use
RU2257221C1 (en) Helminthicide species
Ouled Laghriyeb Study of the process of extracting of the plant collection of expectorant action

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C15 Extension of patent right duration from 15 to 20 years for appl. with date before 31.12.1992 and still valid on 11.12.2001 (patent law change 1993)
OR01 Other related matters
C56 Change in the name or address of the patentee

Owner name: GUANGZHOU MINGXING PHARMACEUTICAL CO., LTD.

Free format text: FORMER NAME OR ADDRESS: MINGXING PHARMACEUTICAL FACTORY, GUANGZHOU

CP03 Change of name, title or address

Address after: 510250 No. 48 Industrial Avenue, Guangzhou, Guangdong, Henan

Patentee after: Guizhou Mingxing Pharmaceutical Co., Ltd.

Address before: 510250 No. 48 Industrial Avenue, Guangzhou, Guangdong, Henan

Patentee before: Mingxing Pharmaceutical Factory

ASS Succession or assignment of patent right

Owner name: GUANGZHOU BAIYUNSHAN MINGXING PHARMACEUTICAL CO.,

Free format text: FORMER OWNER: GUANGZHOU MINGXING PHARMACEUTICAL CO., LTD.

Effective date: 20060303

C41 Transfer of patent application or patent right or utility model
TR01 Transfer of patent right

Effective date of registration: 20060303

Address after: 510250 No. 48 Industrial Avenue, Guangzhou, Guangdong, Henan

Patentee after: Guangzhou Baiyun Shan Ming Xing Pharmaceutical Co., Ltd.

Address before: 510250 No. 48 Industrial Avenue, Guangzhou, Guangdong, Henan

Patentee before: Guizhou Mingxing Pharmaceutical Co., Ltd.

C17 Cessation of patent right
CX01 Expiry of patent term

Expiration termination date: 20121208

Granted publication date: 19980211